Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Trovagene Announces Initiation of UNITE Phase 2 Clinical Trial of PCM-075 in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC)
SAN DIEGO, CA, USA I January 24, 2018 I Trovagene, Inc.
Researchers develop synthetic, bacteria-killing virus
Jan.
Puma Biotechnology sinks after Europe unlikely to OK breast cancer drug
(Reuters) - Puma Biotechnology Inc said on Tuesday a European regulatory panel indicated it was unlikely to provide a positive opinion on the company’s breast cancer drug, sending its shares...
GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences Announce Publication of Landmark Epidiolex® (cannabidiol) Study in The Lancet
LONDON and CARLSBAD, Calif.
ChemoCentryx Announces Positive Overall Survival Results with CCR2 Inhibitor CCX872 for Locally Advanced/Metastatic Pancreatic Cancer
MOUNTAIN VIEW, Calif.
Teva Announces Top-Line Results from Phase III Studies of Subcutaneously Administered Reslizumab in Patients with Severe Eosinophilic Asthma
JERUSALEM--(BUSINESS WIRE)--Jan.
Eureka Therapeutics Closes $60 Million in Series D Financing to Advance Proprietary ARTEMIS™ T Cell Receptor Platform for Safer T Cell Therapies
EMERYVILLE, Calif.
Lupin intros generic Vibra-Tabs
Lupin has introduced its generic Vibra-Tabs (doxycycline hyclate).
Celgene Corporation to Acquire Juno Therapeutics, Inc., Advancing Global Leadership in Cellular Immunotherapy
SUMMIT, N.
Sanofi to Acquire Bioverativ for $11.6 Billion
Paris (France) and Waltham, Mass.
Regen BioPharma, Inc.'s Medicinal Chemistry Program has Identified Additional Compounds That Activate NR2F6
Regen BioPharma, Inc.
Oral Contraceptive Balcoltra Gets FDA Approval
Avion announced that the Food and Drug Administration (FDA) has approved Balcoltra (levonorgestrel and ethinyl estradiol tablets and ferrous bisglycinate tablets), a new oral contracep...
463
464
465
466
467
468
469
470
471
